Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 599, doi. 10.1038/cgt.2010.16
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2010 AND VI 17 AND IP 9
Results: 7
1
2
Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 614, doi. 10.1038/cgt.2010.17
- By:
- Publication type:
- Article
3
Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 624, doi. 10.1038/cgt.2010.19
- By:
- Publication type:
- Article
4
Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 633, doi. 10.1038/cgt.2010.20
- By:
- Publication type:
- Article
5
Antigen quality determines the efficiency of antitumor immune responses generated in the absence of regulatory T cells.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 645, doi. 10.1038/cgt.2010.21
- By:
- Publication type:
- Article
6
Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 655, doi. 10.1038/cgt.2010.22
- By:
- Publication type:
- Article
7
Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
- Published in:
- Cancer Gene Therapy, 2010, v. 17, n. 9, p. 664, doi. 10.1038/cgt.2010.31
- By:
- Publication type:
- Article